Cytarabine and Eosinophilic cystitis - a phase IV clinical study of FDA data
Eosinophilic cystitis is reported only by a few people who take Cytarabine.
The phase IV clinical study analyzes which people take Cytarabine and have Eosinophilic cystitis. It is created by eHealthMe based on reports of 53,624 people who have side effects while taking Cytarabine from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
53,624 people reported to have side effects when taking Cytarabine.
Among them, 2 people (0.0%) have Eosinophilic cystitis.
What is Cytarabine?
Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 53,663 Cytarabine users for its effectiveness, alternative drugs and more.
What is Eosinophilic cystitis?
Eosinophilic cystitis (eosinophiles are present in the bladder wall) is found to be associated with 85 drugs and 42 conditions by eHealthMe.
Number of Cytarabine and Eosinophilic cystitis reports submitted per year:
Gender of people who have Eosinophilic cystitis when taking Cytarabine *:
- female: 0.0 %
- male: 100 %
Age of people who have Eosinophilic cystitis when taking Cytarabine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 100 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Cytarabine *:
- Envarsus Xr: 1 person, 50.00%
Common conditions people have *:
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Cytarabine and have Eosinophilic cystitis?Check whether Eosinophilic cystitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Eosinophilic cystitis and when was it recovered:
Expand to all the drugs that have ingredients of cytarabine:
Alternative drugs to, pros and cons of Cytarabine:
- Cytarabine (53,663 reports)
Common Cytarabine side effects:
- Thrombocytopenia (decrease of platelets in blood): 4,351 reports
- Fever: 4,257 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3,683 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 3,322 reports
- Pneumonia: 2,691 reports
- Hypotension (abnormally low blood pressure): 1,922 reports
Browse all side effects of Cytarabine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Eosinophilic cystitis treatments and more:
- Eosinophilic cystitis (119 reports)
COVID vaccines that are related to Eosinophilic cystitis:
- Eosinophilic cystitis in Moderna COVID Vaccine
- Eosinophilic cystitis in Pfizer BioNTech Covid Vaccine
- Eosinophilic cystitis in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Eosinophilic cystitis:
- Eosinophilic cystitis (86 drugs)
All the conditions that are associated with Eosinophilic cystitis:
- Eosinophilic cystitis (42 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Azelastine Hydrochloride and Lecithin drug interaction - a second ago
- Actos and Multiple Drug Overdose Intentional - 6 seconds ago
- Konakion and Diverticulum Intestinal - 6 seconds ago
- Zyrtec and Ocular Vascular Disorder - 6 seconds ago
- Folic Acid and Adenomyosis - 7 seconds ago
- Indomethacin and Pleurisy - 7 seconds ago
- Bifido and Loss Of Consciousness - 13 seconds ago
- Codeine and Strabismus - 14 seconds ago
- Hexabrix and Hemianopia Homonymous - 19 seconds ago
- Apixaban and Jantoven drug interaction - 36 seconds ago